Design and Rationale for the WARFA Trial: A Randomized Controlled Cross-Over Trial Testing the Therapeutic Equivalence of Branded and Generic Warfarin in Atrial Fibrillation Patients in Brazil
BMC Cardiovascular Disorders - United Kingdom
doi 10.1186/s12872-017-0584-4
Full Text
Open PDFAbstract
Available in full text
Date
June 7, 2017
Authors
Publisher
Springer Science and Business Media LLC